Can VEGFA and ICAM1 polymorphisms predict response to bevacizumab
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.2521
Abstract: 2521Background: Most targeted treatments are associated with biomarkers, predictive of drug response. Although bevacizumab is widely used, there are still no available biomarkers. Given the need of... read more here.
Keywords: predict response; bevacizumab; response; polymorphisms predict ... See more keywords